The first effective cancer vaccine will be widely available in less than 8 years, according to Bushra, a report released yesterday by the man who embellished to the world in November 2020 the news of the development of his Biontech company in Germany, the first vaccine against the new “Corona,” in collaboration with the American Pfizer, the German Professor of Turkish descent, UGur Sahin, and his wife, Professor özlem TüRECI, a specialist in immunodeficiency.
Professor Shaheen stated yesterday that the knowledge gained from the Curon epidemic will speed up the processing of the known messor RNA technology, also known as ribonucleic acid (RNA) or “Rebuzi DNA,” which is present in all living things and viruses. It serves a variety of functions by transporting, encrypting, deciphering, and expressing genetic information as well as inducing numerous chemical reactions.
According to his wife, who founded the business in 2008 in Mainz, southwest Germany, “What we developed for decades to develop a cancer vaccine was a background to develop a Covid-19 vaccine that has become part of our work in the field of cancer,” she told a BBC TV reporter. She also said that they learned how to manufacture the vaccines “better and faster, as well as how the immune system interacts with the Mercy Rana in a large number of people” according to its expression.
The professor of Turkish descent noted that the advancements had also assisted the designers in determining which vaccinations were “messengers” and how to handle them, which would undoubtedly speed up the creation of our cancer vaccine.
We believe that treating cancer or improving the lives of cancer patients is within our grasp. Additionally, we believe that scientists should display humility because there are many mysteries in biology and nature, but every step of an experiment or treatment helped them learn more about the conditions we oppose and the best ways to treat them. In the video, we see more promising MRNA.
The interview makes it obvious that the cancer vaccinations will function similarly to the Corona vaccine in that they instruct the body to produce “antigen” molecules in the tumour so that it can recognise and eliminate any leftover cells after surgery.
Since pancreatic cancer is the most lethal species and 90% of those with it die within two years of diagnosis, the Biontech presented the findings of an early experience of pancreatic cancer patients at the American Association for Clinical Oncology in Chicago last June. It was discovered that half of those who received the 16s, who were ill, got rid of it after 18 months, while 8 others had no response to T-cells and 6 of those who returned to them died.
In order to protect those who have already had a disease from returning, the next generation of cancer vaccines also attempts to immunise them. It will also be used to teach the body to identify the “antigens” or chemical names found in the tumor of the sick person, so that the immune system can identify any cells and throwing that remained in the body after removing the tumor to destroy them..
The Turkish, who created the first Corona vaccine, advocates for another cancer
About Author
